Access Pharmaceuticals Announces Granting of Two US Patents for ...(nical testing of patients with ovarian c...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
Date:6/10/2009
nical testing of patients with ovarian cancer, and MuGard(TM) for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin(TM)-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.
This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.
'/>"/>
| SOURCE Access Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
2. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
3. Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com
4. Access Highlighted in Recent BusinessWeek Article
5. GeneGo Enters Multi-Year Agreement With Bristol Myers Squibb for Access to GeneGo Software Suite and Databases
6. CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care
7. Monitorforhire.com Adds Mobile Phone Capability Further Speeding Access to Experienced Monitors
8. Pharmasset Accesses up to $30 Million of Working Capital
9. Access Genetics Announces New Executive Appointments
10. Access Pharmaceuticals Announces $19.5 Million Recapitalization
11. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
Post Your Comments:
Breaking Biology Technology:Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes 2Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3
[0] Nutek, LLC Introduces New Soy-Based, Biodegradable Lubricating and Cleaning Wipes[0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property[0] Reportlinker Adds Pharmacodynamic Assays[0] Vivakor Announces Mechanics of Dividend Distribution
Other Biology Technology:CryoLife Announces Management Promotions 2CryoLife Announces Management Promotions 3Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research 2
Breaking Biology News(10 mins):U. of I. business instructional facility achieves top 'green' standard 2U. of I. business instructional facility achieves top 'green' standard 3Rodent smoke screen 2Plate-eating good: Université de Montréal professor designs edible tableware 2U S Spending on Mental Health Care Soaring 53778 1U S Spending on Mental Health Care Soaring 53778 2Social Stress Sends Body Fat to the Stomach 53776 1Social Stress Sends Body Fat to the Stomach 53776 2Exciton Technologies receives FDA approval to market exSALT 28TM 29 13400 1Exciton Technologies receives FDA approval to market exSALT 28TM 29 13400 2Exciton Technologies receives FDA approval to market exSALT 28TM 29 13400 3
Other Biology News:Complex ocean behavior studied with 'artificial upwelling' 2Complex ocean behavior studied with 'artificial upwelling' 3Complex ocean behavior studied with 'artificial upwelling' 4Broad Institute awarded grant to develop chemical probes for human biology and disease 2Broad Institute awarded grant to develop chemical probes for human biology and disease 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |